Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

D Abdourahimi1, D Yehadji1, E Briskin2

  • 1Médecins Sans Frontières (MSF), Conakry, Guinée.

Public Health Action
|August 2, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to the Union's statement on ongoing conflicts and impact on health services.

IJTLD open·2026
Same author

Sustained treatment success at 12 months for drug-resistant TB patients on concomitant bedaquiline-delamanid.

IJTLD open·2025
Same author

Role of M<sub>4</sub> -receptor cholinergic signaling in direct pathway striatal projection neurons during dopamine depletion.

Synapse (New York, N.Y.)·2024
Same author

Public health action·2023
Same author

Public health action·2023
Same author

Clinical standards for drug-susceptible TB in children and adolescents.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same journal

Compliance with intermittent preventive malaria treatment in pregnancy at a tertiary hospital in Sierra Leone.

Public health action·2026
Same journal

From fellows to leaders: lessons learned from the WHO/TDR Clinical Research and Development Fellowship (1999-2021).

Public health action·2026
Same journal

Comprehensive assessment of adults severely ill with TB referred after triage in Tamil Nadu, India.

Public health action·2026
Same journal

Tuberculosis preventive therapy in Sierra Leone: early implementation gaps and lessons learned.

Public health action·2026
Same journal

Effectiveness and challenges of DOT in multidrug-resistant TB: a 12-year retrospective study.

Public health action·2026
Same journal

Unmasking the appeal - tobacco and vaping companies have recruited a new generation of nicotine dependents.

Public health action·2026
See all related articles

Advanced HIV patients aged 25 and older, especially those with respiratory or abdominal symptoms, face higher mortality risks within the first 25 days of hospitalization. Increased surveillance is crucial for these high-risk individuals.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Context:

  • Médecins Sans Frontières (MSF) supports a unit for advanced HIV patients at Donka National Hospital, Conakry, Guinea.
  • The study focuses on patient data from 2017-2021.

Purpose:

  • To identify factors associated with mortality in hospitalized patients with advanced HIV.
  • To inform targeted interventions for reducing deaths in this vulnerable population.

Summary:

  • A retrospective analysis of 3,718 advanced HIV patients revealed a mean mortality rate of 33.6%.
  • Key mortality predictors included age (25-49 and ≥50 years), respiratory or abdominal symptoms, and hospital readmission.
  • The initial 25 days of hospitalization represented the highest risk period for death, with tuberculosis and toxoplasmosis as frequent diagnoses.

Related Experiment Videos

Impact:

  • Highlights the critical need for enhanced surveillance of older patients and those with specific symptoms.
  • Emphasizes the importance of early detection and management of opportunistic infections like TB and toxoplasmosis.
  • Provides data to guide resource allocation and clinical strategies in HIV care settings with limited resources.